Aurinia Pharmaceuticals
AUPH
AUPH
170 hedge funds and large institutions have $317M invested in Aurinia Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 46 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% less funds holding
Funds holding: 178 → 170 (-8)
19% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 31
Holders
170
Holding in Top 10
–
Calls
$10.2M
Puts
$6.94M
Top Buyers
| 1 | +$3.84M | |
| 2 | +$3.53M | |
| 3 | +$3.21M | |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$2.92M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.58M |
Top Sellers
| 1 | -$5.92M | |
| 2 | -$2.13M | |
| 3 | -$1.99M | |
| 4 |
Morgan Stanley
New York
|
-$1.67M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.45M |